Gut-Brain-Axis Therapeutics Inc. filed an amended Form D with the Securities and Exchange Commission on 2026-10-27.
Gut-Brain-Axis Therapeutics Inc. filed an amended Form D notice of an exempt securities offering with the SEC on October 27, 2026. The filing reports $1.97M sold. Its industry group is Biotechnology. It names James Adams (Executive Officer, Director), Alexander Khoruts (Director), Rosa Krajmalnik-Brown (Director) (SEC Form D/A, October 27, 2026).
Is this your company?
Sell to companies like Gut-Brain-Axis Therapeutics Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-27 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Gut-Brain-Axis Therapeutics Inc.
Free to see. No signup.
More on the people and the money behind Gut-Brain-Axis Therapeutics Inc., from the filings we hold.
Biotechnology raises filed within 90 days of this one, largest first.
Get an email when Gut-Brain-Axis Therapeutics Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Gut-Brain-Axis Therapeutics Inc. raises, hires or launches. No email unless you switch it on.
Watch Gut-Brain-Axis Therapeutics Inc. →Get the full cited report on Gut-Brain-Axis Therapeutics Inc.
What the filing shows about Gut-Brain-Axis Therapeutics Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Gut-Brain-Axis Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Gut-Brain-Axis Therapeutics Inc.'s address as 1340 E Vinedo Lane, Tempe, AZ 85284.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Gut-Brain-Axis Therapeutics Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Gut-Brain-Axis Therapeutics Inc. See pricing
Gut-Brain-Axis Therapeutics Inc. is a registered filer with the SEC (CIK 1996678) and has filed since 2023-10-10. 2 filings are on record, the latest on 2025-11-06.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Gut-Brain-Axis Therapeutics Inc.'s Form D of 2026-10-27 names James Adams, Alexander Khoruts, Rosa Krajmalnik-Brown and 1 more as its officers, directors or promoters.
Its new offerings report $3.40M sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 764 filings in Biotechnology, totalled by week. The dot is this raise, $1.97M, on the same scale — one filing against the whole group's total, so it sits low by construction.
The gross proceeds of the offering will be used for operating expenses, working capital and other general corporate purposes.
James Adams is named as Executive Officer and Director on the Form D that Gut-Brain-Axis Therapeutics Inc. filed with the SEC on 27 October 2026, one of 4 people that filing names.
Alexander Khoruts is named as Director on the Form D that Gut-Brain-Axis Therapeutics Inc. filed with the SEC on 27 October 2026, one of 4 people that filing names.
Rosa Krajmalnik-Brown is named as Director on the Form D that Gut-Brain-Axis Therapeutics Inc. filed with the SEC on 27 October 2026, one of 4 people that filing names.
Michael Sadowsky is named as Director on the Form D that Gut-Brain-Axis Therapeutics Inc. filed with the SEC on 27 October 2026, one of 4 people that filing names.
4 people named on the filing — 1 holding an executive role and 3 as directors only.
Named as of the 2026-10-27 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Gut-Brain-Axis Therapeutics Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Gut-Brain-Axis Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Gut-Brain-Axis Therapeutics Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Gut-Brain-Axis Therapeutics Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Gut-Brain-Axis Therapeutics Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Gut-Brain-Axis Therapeutics Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/gut-brain-axis-therapeutics-inc-form-d-000001